A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Protocol for Studying Honokiol Regulation of Transforming Growth Factor Beta 1/Smad Signaling in Ultraviolet A–induced Skin Photoaging Models

208 views

⸱

DOI:

10.3791/70099

⸱

May 8th, 2026

 ,  ,  , 
1Plastic Surgery Center, the 988th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army

In This Article

Summary

This protocol investigates whether honokiol ameliorates UVA-induced photo-aging in human dermal fibroblasts and mouse skin by activating the TGF-β1/Smad pathway and reducing MMP expression.

Abstract

Honokiol (HNK), a key component derived from Magnolia officinalis, has the potential to treat skin diseases. At present, the impact and mechanism of action of HNK on Ultraviolet A (UVA)-induced photodamage in the skin are unclear. A photo-aging damage model of HDF cells and hairless mouse skin was constructed by UVA induction. The impact of HNK on the viability of normal HDF cells and UVA-induced HDF cells was examined through the Cell viability assay. SOD, GSH, CAT, and MDA levels in HDF cells were measured using different kits, and ROS levels were measured using DCFH-DA and Dihydroethidium. SA-β-galactosidase and TUNEL staining detected senescence and apoptosis in HDF cells, and flow cytometry assessed cell cycle progression. Histopathological damage to the skin was evaluated through pathological staining. In addition, immunofluorescence and Western blot were used to assess Ki67, collagen, matrix metalloproteinase (MMP), and TGF-β1/Smad pathway-associated protein levels. HNK (2.5-10 µM) treatment had no adverse impact on normal HDF cell viability but attenuated UVA-induced HDF cell damage, reducing oxidative stress and apoptosis. UVA induced senescence of HDF cells, induced S-phase arrest, downregulated Ki67, decreased collagen content, and increased MMP expression, while HNK effectively attenuated these UVA-induced abnormalities. In addition, UVA caused deeper wrinkles, decreased water content and collagen content, and increased epithelial thickness in mouse skin, whereas subcutaneous injection of HNK attenuated pathological damage to skin tissue and increased water and collagen content. Furthermore, HNK activated the TGF-β1/Smad pathway, and the TGF-β1 inhibitor SB431542 impaired the protective effect of HNK against photo-aging damage in HDF cells. In conclusion, HNK has the potential to be a drug for ameliorating photo-aging damage by reducing MMP expression through activation of the TGF-β1/Smad pathway, thereby inhibiting UVA-induced photo-aging in HDF cells and mouse skin.

Introduction

The process of skin aging is intricate and divided into two main forms: natural aging and photo-aging1. Studies indicate that as much as 80% to 90% of skin aging is caused by exogenous factors in the environment (e.g., ultraviolet rays, air pollution), of which long-term ultraviolet radiation-induced photo-aging has the most serious effects2,3. Ultraviolet radiation is divided into UVC, UVB, and UVA. Since UVC cannot penetrate the ozone layer, current research on photo-aging focuses on UVA (320-400 nm) and UVB (280-320 nm)4,5,6. Compared with UVB, UVA has lower energy, but it is more penetrating, passing through the epidermis and reaching deep into the dermis, which is an important cause of serious skin aging7. Previous studies have shown that the damage caused by 57 mJ/cm2 UVB and 20 J/cm2 UVA irradiation to HaCaT cells is comparable8. Skin photo-aging causes changes in the function and structure of the skin, specifically manifested as skin surface tissue sagging, deepening wrinkles, loss of collagen, and the appearance of gray skin color visible to the naked eye; in severe cases, a variety of benign, precancerous lesions and tumors can occur9,10. Along with the increase in research on aging and anti-aging, the health risks of photoaging have become one of the most important health concerns worldwide. Therefore, it is crucial to investigate the pathophysiological processes underlying UVA-induced photo-aging damage, with a view to developing new therapeutic options for its treatment.

Extracted from Magnolia officinalis, a traditional Chinese medicinal herb, Honokiol (HNK) is a significant bioactive compound with the chemical formula of C18H18O211. HNK exhibits various pharmacological activities, and its phenolic hydroxyl group is highly susceptible to oxidation and has strong antioxidant and free radical scavenging effects12. In addition, HNK has antibacterial, anti-inflammatory, antiviral, antitumor, antidepressant, neuroprotective, and anti-premature ovarian failure pharmacological effects13,14,15,16. Oral HNK has been determined to be essentially safe in animal studies and clinical studies, and no significant adverse effects have been identified17,18,19. Recent studies have found that HNK prevents UVB-induced skin cancer20, and inhibits UVB-induced skin inflammatory response and DNA hypermethylation21, suggesting its potential use in treating skin conditions. Compared with widely used anti-photo-aging agents, including vitamin C and resveratrol, HNK has distinct and superior properties: its lipophilic structure confers better transdermal permeability than hydrophilic vitamin C22; and it exhibits higher photostability and in vivo bioavailability than resveratrol23. These preclinical findings support the notion that HNK has promising translational potential as a safe and effective candidate for skincare products and clinical interventions against ultraviolet-induced skin photodamage. However, the impact of HNK treatment on skin photo-aging damage caused by UVA has not yet been reported.

Transforming growth factor-β1 (TGF-β1) is a multifunctional cytokine crucial for cell growth and development, tissue repair and regeneration, and the growth and development of cells, tissues, and organs24,25. It has been shown that TGF-β1 signals to the cell primarily through members of the Smad protein family, leading to the specific regulation of transcription of downstream target genes. When TGF-β1 signaling is activated, it results in phosphorylation of Smad2 and Smad326,27. Recent studies have shown a strong connection between the TGF-β1/Smad pathway and skin fibrosis and photo-aging28,29. It has been reported that the mammalian target of rapamycin activates the TGF-β1/Smad pathway in rat skin tissues, which in turn promotes the synthesis of ceramides, which are important for retaining skin moisture and maintaining the skin barrier30. Notably, it has been reported that HNK modulated the TGF-β1/Smad pathway in hepatic stellate cells, which, in turn, ameliorated liver fibrosis31. Therefore, cellular and mouse models of UVA-induced photo-aging injury were established, with 2.5–10 µM HNK treatment in HDF cells and 5 mg/kg or 10 mg/kg HNK intervention in hairless mice, to explore the effects of HNK on photo-aging damage and its potential role in modulating the TGF-β1/Smad pathway. This study aimed to develop new therapeutic strategies for UVA-induced skin photodamage.

Access restricted. Please log in or start a trial to view this content.

Protocol

All cell culture experiments were performed in accordance with institutional biosafety guidelines and conducted under Biosafety Level 2 (BSL-2) laboratory conditions. Animal experiments were performed after approval from the Animal Ethics Committee of the 988th Hospital of the Joint Logistic Support Force of the Chinese People’s Liberation Army (approval number: 2023-089).

All experimental procedures were conducted in strict accordance with institutional and national guidelines for the care and use of laboratory animals. At the end of the experiment, mice were euthanized via an overdose of sodium pentobarbital (100 mg/kg, intraperitoneal injection). All efforts were made to minimize animal suffering during housing, treatment, and sampling procedures. The reagents, chemicals, equipment, and software used in the protocol are listed in the Table of Materials.

1. Cell culture and processing

  1. Culture human dermal fibroblasts (HDF) in fibroblast culture medium. Maintain cultures at 37 °C in a saturated-humidity environment with 5% CO2.
  2. Replace the culture medium every 3 days, and passage HDF at a ratio of 1:3 when confluent.
  3. Irradiate HDF with UVA lamps (emission spectrum: 320-400 nm) at a dose of 5 J/cm2.
  4. Replenish with fresh medium immediately after 30 min of UVA irradiation. Repeat UVA irradiation once daily for 8 consecutive days32.
  5. Treat HDF with 2.5, 5, 10, 20, or 40 µM HNK for 24 h or 48 h in the dose-screening experiments33. Treat HDF with 2.5, 5, or 10 µM HNK for 24 h followed by UVA irradiation (5 J/cm2) in subsequent experiments.
  6. Expose HDF to 10 µM HNK for 4 h, then incubate with 10 µM TGF-β1 inhibitor SB431542 for 24 h, and finally irradiate with UVA (5 J/cm2) in the HNK+SB431542 group.

2. Cell viability assessment

  1. Inoculate HDF into 96-well cell culture plates at a density of 1×104 cells/well.
  2. After different treatments, add 10 µL of 10% water-soluble tetrazolium salt reagent to each well to a final volume of 100 µL per well, and incubate the cells at 37°C for 1.5 h in the dark.
  3. Measure the OD450 values of the cells using a microplate reader.

3. Determination of superoxide dismutase (SOD), malondialdehyde (MDA), catalase (CAT), and glutathione (GSH) levels

  1. Wash HDF with 1 mL pre-cooled PBS (0.01 M, pH 7.4), add 200 µL SOD sample preparation solution (from SOD Assay Kit) to lyse cells on ice for 15 min.
  2. Centrifuge the lysate at 8000 × g for 5 min at 4 °C, and collect the supernatant as the assay sample.
  3. Use a BCA (Bicinchoninic Acid) protein assay kit to determine the protein concentration of the supernatant, and adjust the sample to 50 µg total protein in a 50 µL volume.
  4. Mix the 50 µg protein sample with the SOD assay buffer to a final reaction volume of 200 µL, and incubate the mixture at 37 °C for 30 min in the dark, and then measure the OD450 value.
  5. Take the same cell lysate supernatant used for the SOD assay, measure CAT, GSH, and MDA levels using the respective assay kits.

4. Measurement of cellular ROS levels

  1. Treat HDF cells with different conditions, rinse twice with 500 µL PBS, and mix well with 500 µL of 10 µM reactive oxygen species fluorescent probe and incubate at 37 °C for 20 min away from light.
  2. Centrifuge at 1000 × g for 5 min at room temperature to collect the cells, and then rinse two times with 500 µL PBS.
  3. Resuspend the cells in 500 µL cell culture medium, and then analyze the staining by flow cytometry.
  4. Record fluorescence intensity using flow cytometry analysis software, and then calculate ROS levels based on the fluorescence intensity higher ROS corresponds to stronger green fluorescence).

5. Senescence-associated β-galactosidase (SA-β-galactosidase) staining

  1. Seed HDF into 6-well cell culture plates at a density of 1×106 cells/well and culture to adherence. After different treatments, wash HDF once with 2 mL PBS.
  2. Add 1 mL β-galactosidase staining fixative to each well, and incubate the cells at room temperature with fixative for 15 min.
  3. Wash the cells 3 times with 2 mL PBS, add 1 mL staining working solution to each well, and then incubate at 37°C overnight in the dark.
  4. Observe and photograph the cells using a light microscope (senescent cells appear blue).

6. Cell cycle assay

  1. Seed HDF into 6-well plates at 1×106 cells/well; after different treatments, rinse cells twice with 2 mL PBS.
  2. Centrifuge at 1000 × g for 5 min at room temperature to collect cells, add 1 mL of 70% ethanol (cell fixative), and mix gently by pipetting. Place the fixed cells in a 4°C refrigerator for 12 h.
  3. Prepare 500 µL per sample of cell staining solution by mixing propidium iodide (PI, final concentration 50 µg/mL) and RNaseA (final concentration 200 µg/mL) in PBS. Expose cells to 500 µL of staining solution, incubate in the dark at 37°C for 30 min.
  4. Assess fluorescence intensity using flow cytometry. Perform cell-cycle analysis using a flow cytometer.

7. TUNEL staining

  1. Expose HDF cells from different treatment groups to 1 mL of 4% paraformaldehyde and incubate at room temperature for 30 min.
  2. Add 1 mL of PBS containing 0.3% Triton X-100 to the cells and incubate at room temperature for 5 min.
  3. Wash the cells twice with PBS, then add 500 µL TUNEL assay solution dropwise to evenly cover the cells. Incubate at 37°C in the dark for 1.5 h.
  4. Add 200 µL of DAPI staining solution to cover the cells, and incubate away from light for 10 min at 25 °C.
  5. Seal the cells with a fluorescence signal-preservation mounting medium, then observe and photograph them using a fluorescence microscope (TUNEL-positive cells show green fluorescence).

8. Immunofluorescence staining

  1. Seed HDF cells from different treatment groups into 12-well plates. Once the cell density reaches 50%-60%, expose the cells to 1 mL of 4% paraformaldehyde and incubate at room temperature for 25 min.
  2. Add 1 mL of 5% bovine serum albumin (BSA) dropwise to block the cell surface, and incubate at room temperature for 30 min.
  3. Add 500 µL of primary antibodies Ki67 (1:300), collagen I (1:100), matrix metalloproteinase (MMP)-1 (1:50), or MMP-3 (1:100) dropwise, and incubate at 4°C overnight.
  4. On the following day, incubate the cells with 500 µL of fluorescein isothiocyanate (FITC)-labeled secondary antibody (1:100) at 37°C away from light for 1 h.
  5. Add 200 µL of DAPI staining solution to cover the cells, incubate away from light for 10 min, observe using a fluorescence microscope, and analyze with image analysis software (collagen I and MMP-1 positive cells show red fluorescence, Ki67 and MMP-3 positive cells show green fluorescence).

9. ELISA

  1. Add 100 µL of HDF cell culture supernatant to wells of MMP-1 or MMP-3 ELISA kit plates, and incubate at 37°C for 2 h.
  2. Wash the wells 3 times with 200 µL of PBS, then add 100 µL of the corresponding antibody to each well and incubate at 37 °C in the dark for 1 h.
  3. Rinse the wells 3 times with 200 µL of washing buffer (provided in the kit), shake off excess solution, and incubate the samples with 100 µL of streptavidin-HRP for 30 min at 37°C in the dark.
  4. After rinsing with PBS, add 100 µL of substrates A and B according to the kit instructions and incubate at 37°C in the dark for 10 min.
  5. Add 50 µL of termination solution, mix well, assess the OD450 value using a microplate reader, and calculate the concentration.

10. Photo-aging damage mouse model construction

  1. House SPF-grade female SKH1 hairless mice (15-20 g, 4-5 weeks old) at 22 °C with 55%-60% humidity and allow autonomous access to food and water. Disinfect facilities regularly, including food containers, water bottles, and drinking spouts.
  2. Randomly assign mice to the control group (n=6) and the model group (n=18). Irradiate model group mice with UVA at 0.35 J/cm2 for 8 weeks34; house control group mice in the same environment without UVA irradiation.
  3. Divide the model group mice equally into 3 subgroups (n=6 each).
  4. Administer subcutaneous injections of HNK at 5 mg/kg or 10 mg/kg in 100 µL volume twice a week to two subgroups during UVA irradiation (record as the 5 mg/kg HNK group and 10 mg/kg HNK group, respectively). Administer subcutaneous injections of 100 µL saline twice a week to the third subgroup during UVA irradiation (record as UVA group).
  5. Evaluate skin wrinkle formation and water content after successful modeling35.
  6. Euthanize mice with sodium pentobarbital (100 mg/kg) intraperitoneally, and then collect dorsal skin tissues for further experiments.

11. Measurement of skin collagen I content

  1. Collect 50 mg of mouse dorsal skin tissues, grind them thoroughly in liquid nitrogen, and lyse them using 500 µL of pre-cooled RIPA lysis buffer for 30 min on ice.
  2. Centrifuge the lysate at 8000 × g for 5 min at 4 °C, collect the supernatant, and measure the collagen content using a pro-collagen I C peptide assay kit according to the manufacturer’s instructions.

12. Hematoxylin and eosin (HE) staining

  1. Fix mouse skin tissues in 10 mL 4% paraformaldehyde at room temperature for 24 h, dehydrate in gradient ethanol (50%, 75%, 95%, 100%, each for 5 min), embed in paraffin, and section into 4 µm slices.
  2. Bake the slices at 65°C for 8 h, deparaffinize in xylene twice for 10 min each, and rehydrate in gradient ethanol at room temperature.
  3. Stain the slices with hematoxylin solution for 8 min, rinse with running tap water for 1 min, differentiate with differentiation solution for 30 s, and stain with eosin for 1 min at room temperature.
  4. Dehydrate the stained slices in gradient ethanol, clear in xylene, seal with mounting medium, and observe under a microscope (The cell nucleus appears blue-purple, while the cytoplasm, collagen fibers, and erythrocytes appear pink to varying degrees).

13. Masson staining

  1. Stain paraffin sections of mouse skin tissues using Masson trichrome staining kit36. Deparaffinize paraffin sections in xylene twice for 10 min each, add Weigert iron hematoxylin staining solution, and stain for 10 min.
  2. Differentiate with acid ethanol differentiation solution for 30 s, rinse with running tap water for 5 min, then stain with Ponceau-fuchsin staining solution dropwise for 10 min at room temperature. Perform reverse bluing with Masson's blue solution and then rinse with distilled water for 1 min.
  3. Prepare a weak acid working solution at a ratio of distilled water: weak acid solution (provided in the kit) = 2:1; add 1 mL weak acid working solution dropwise and wash for 30 s at room temperature.
  4. Pour off excess liquid, add 1 mL phosphomolybdic acid solution dropwise, and treat for 2 min at room temperature. Add 1 mL of the weak acid working solution dropwise, then wash for 30 s.
  5. Pour off excess liquid, add 1 mL aniline blue staining solution dropwise and stain for 1 min. Add 1 mL weak acid working solution dropwise and wash for 30 s.
  6. Dehydrate quickly in 95% ethanol for 2 s. Dehydrate in absolute ethanol twice, 10 s each time.
  7. After drying, clear the sections in xylene, and mount with neutral gum. Observe the distribution of collagen fibers in each group under a microscope (Collagen fibers appear blue, while muscle fibers, cytoplasm, and erythrocytes are bright red, and cell nuclei appear distinctly blue-black).

14. Measurement of skin tissue ROS levels

  1. Take frozen sections of mouse skin tissue (prepared within 1 h of excision), spread 1 mL cleaning solution dropwise over the entire section surface, and let stand at room temperature for 10 min.
  2. Shake off the washing solution, then add 1 mL of 10 µM Reactive oxygen species probe dropwise to evenly cover the sections; incubate at 37 °C away from light for 30 min.
  3. Rinse the sections twice with PBS, add cover slips, and observe using a fluorescence microscope (ROS-positive areas exhibit red fluorescence; the lower the ROS level, the weaker the red fluorescence signal).

15. Biochemical indicators testing

  1. Collect mouse serum and prepare detection reagents according to the instructions of the corresponding assay kits.
  2. Measure the activities of aspartate transaminase (AST) and alanine transaminase (ALT) in mouse serum using the respective kits.
  3. Determine the levels of blood urea nitrogen (BUN) and creatinine (CRE) in mouse serum using the respective kits.

16. Western blot

  1. Collect 50 mg of tissue or 1×106 cells, lyse the samples on ice for 30 min using 200 µL RIPA lysis buffer to obtain proteins.
  2. Centrifuge at 8000 × g for 5 min at 4 °C and collect the supernatant. Assess protein content in cells and tissues using the BCA protein concentration assay kit.
  3. Perform electrophoresis of sample proteins on 12% SDS-PAGE gel, and transfer separated proteins to PVDF membranes at 4 °C.
  4. Block PVDF membranes with 5% BSA for 3 h at room temperature. Rinse the membranes with TBST (contains 20 mM Tris-HCl, 150 mM NaCl, and 0.1% Tween-20) 3 times, then incubate overnight at 4°C with primary antibodies: P53 (1:1000), P21 (1:1000), P16 (1:100), collagen I (1:1000), Cyclin A2 (1:500), Cyclin-dependent kinase 2 (CDK2, 1:1000), MMP-1 (1:500), MMP-3 (1:1000), TGF-β1 (1:1000), Smad2 (1:100), Smad3 (1:1000), p-Smad2 (1:1000), or p-Smad3 (1:1000).
  5. On the second day, wash the membranes with TBST 3 times, then incubate with 1 mL of goat anti-rabbit IgG (1:10000) at room temperature for 2 h. Apply 500 µL of the enhanced chemiluminescence (ECL) reagent evenly to the membranes, then scan them using a gel imaging system.
  6. Perform gray value analysis using image analysis software. Express the relative expression level as the ratio of its gray value to that of GAPDH.

17. Statistical analysis

  1. For in vitro cell-based assays, all experiments are independently repeated thrice (n=3, biological replicates).
  2. For in vivo animal experiments, 6 mice are included per group (n=6), which complies with the 3R principles for laboratory animal welfare and ethics.
  3. All results are expressed as mean ± standard deviation. Perform statistical analysis using statistical analysis software. Data normality was tested using the Shapiro-Wilk test.
  4. For normally distributed data, use one-way ANOVA for multi-group comparison, followed by Tukey’s post-hoc test for pairwise comparisons between groups. For non-normally distributed data, apply the nonparametric Kruskal-Wallis test. P< 0.05 indicates a significant difference.
  5. Generate graphs using graphing software.

Access restricted. Please log in or start a trial to view this content.

Results

HNK alleviates oxidative stress damage in HDF cells caused by UVA
The impacts of various concentrations of HNK treatment for 24 h or 48 h on the viability of HDF cells were examined by Cell viability assay to screen for the appropriate concentration and treatment duration. The results showed that 2.5, 5, and 10 µM of HNK did not significantly affect the viability of normal HDF cells after 24 h or 48 h of treatment, demonstrating that HNK is non-toxic to normal cells at these doses. Notably, HNK at co...

Access restricted. Please log in or start a trial to view this content.

Discussion

Ultraviolet light is one environmental factor that harms cells and organisms. Previous studies have reported that UVA, with its high penetrating power, is the main type of ultraviolet light that reaches the Earth's surface38. Fibroblasts are important functional cells in the dermis, and their aging can directly or indirectly cause skin aging39. UVA-induced photo-aging damage in the HDF cell model and the hairless mouse model is widely used in the study of skin photo-aging

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors affirm that they have no financial conflicts of interest.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
ALT activity assay kitBeyotime Biotechnology, Shanghai, ChinaP2711Malanine transaminase activity detection kit
Amplex Red CRE assay kitBeyotime Biotechnology, Shanghai, ChinaS0291Screatinine detection kit
AntiFade mounting mediumBeyotime Biotechnology, Shanghai, ChinaP0126fluorescence signal preservation mounting medium
AST activity assay kitBeyotime Biotechnology, Shanghai, ChinaP2715Saspartate transaminase activity detection kit
BCA protein assay kitBeyotime Biotechnology, Shanghai, ChinaP0012protein concentration determination kit
BSASigma-Aldrich, St. Louis, MO, USAV900933blocking reagent for non-specific binding
BUN Assay kitBeyotime Biotechnology, Shanghai, ChinaS0574Sblood urea nitrogen detection kit
CAT Assay kitBeyotime Biotechnology, Shanghai, ChinaS0051catalase activity detection kit
CCK-8 reagentSigma-Aldrich, St. Louis, MO, USA96992cell viability assay solution which is a water-soluble tetrazolium salt
CDK2 antibodyInvitrogen, Carlsbad, CA, USAPA5-79024primary antibody for CDK2 detection
Chemiluminescent agent ECLMedChemExpress, Monmouth Junction, NJ, USAHY-K1005enhanced chemiluminescence detection reagent
Collagen I antibodyInvitrogen, Carlsbad, CA, USAPA1-26204primary antibody for collagen I detection
Cyclin A2 antibodyInvitrogen, Carlsbad, CA, USAPA5-34682primary antibody for Cyclin A2 detection
DAPI staining solutionSigma-Aldrich, St. Louis, MO, USAD9542nuclear staining dye
DCFH-DA fluorescent probeMedChemExpress, Monmouth Junction, NJ, USAHY-D0940reactive oxygen species fluorescent probe
Differentiation solutionBeyotime Biotechnology, Shanghai, ChinaC0161sreagent for hematoxylin differentiation step
Dihydroethidium probeBeyotime Biotechnology, Shanghai, ChinaS0063reactive oxygen species probe
Fibroblast culture mediumSunncell Biotechnology Co., Ltd., Wuhan, Hubei, ChinaSNPM-H342complete culture medium for fibroblast growth
FITC-labeled goat anti-rabbit IgGInvitrogen, Carlsbad, CA, USAF-2765fluorescein isothiocyanate (FITC)-labeled secondary antibody
Flow cytometryBD biosciences, San Jose, CA, USABD FACSCaliburTMflow cytometer
FlowJo softwareBD biosciences, San Jose, CA, USAv10.8flow cytometry analysis software
Fluorescence microscopeLeica, Heidelberg, GermanyDM IL LEDmicroscope for fluorescence imaging
GAPDH antibodyInvitrogen, Carlsbad, CA, USAPA1-987internal control antibody for protein normalization
gel imaging systemInvitrogen, Carlsbad, CA, USAiBright CL1500imaging system for protein detection
goat anti-rabbit IgGInvitrogen, Carlsbad, CA, USA31460secondary antibody for immunodetection
Graphpad Prism 9.0 softwareGraphPad Software, San Diego, CA, USAPrism 9.0graphing software
GSH Assay kitBeyotime Biotechnology, Shanghai, ChinaS0053glutathione content detection kit
HE staining kitBeyotime Biotechnology, Shanghai, ChinaC0105Shistological staining kit for tissue morphology analysis
HNKMedChemExpress, Monmouth Junction, NJ, USAHY-N0003honokiol, bioactive compound
Human dermal fibroblastsSunncell Biotechnology Co., Ltd., Wuhan, Hubei, ChinaSNP-H342primary human skin fibroblast cells
IBM SPSS Statistics 26.0 softwareIBM Corporation, Armonk, NY, USAIBM SPSS Statistics 26.0statistical analysis software
ImageJ softwareWayne Rasband, National Institute of Mental Health, USAversion 1.54himage analysis software
Ki67 antibodyInvitrogen, Carlsbad, CA, USAMA5-14520primary antibody for cell proliferation marker detection
Light microscopeLeica, Heidelberg, GermanyDM3000optical microscope for brightfield imaging
Masson trichrome staining kitSolarbio, Beijing, ChinaG1340collagen and connective tissue staining kit
MDA Assay kitBeyotime Biotechnology, Shanghai, ChinaS0131Smalondialdehyde level detection kit (lipid peroxidation marker)
Microplate ReaderThermo Fisher Scientific, Waltham, MA, USA1410101absorbance measurement instrument for cell-based assays
MMP-1 antibodyInvitrogen, Carlsbad, CA, USAPA5-27210primary antibody for matrix metalloproteinase-1 detection
MMP-1 ELISA kitEnzyme-linked Biotechnology, Shanghai, Chinaml038199quantitative detection of MMP-1 in biological samples
MMP-3 antibodyAbcam, Cambridge, MA, USAab52915primary antibody for matrix metalloproteinase-3 detection
MMP-3 ELISA kitEnzyme-linked Biotechnology, Shanghai, Chinaml105322quantitative detection of MMP-3 in biological samples
Neutral gumBeyotime Biotechnology, Shanghai, ChinaC0173mounting medium
P16 antibodyInvitrogen, Carlsbad, CA, USAPA5-20379primary antibody for p16 protein detection
P21 antibodyInvitrogen, Carlsbad, CA, USAMA5-14949primary antibody for p21 protein detection
P53 antibodyAbcam, Cambridge, MA, USAab131442primary antibody for p53 protein detection
paraformaldehydeSolarbio, Beijing, ChinaP1110cell and tissue fixation reagent
PIBeyotime Biotechnology, Shanghai, ChinaST512propidium iodide for DNA staining in cell cycle analysis
Pro-collagen I C peptide assay kitTAKARA, Tokyo, JapanMK101collagen synthesis detection kit
p-Smad2 antibodyInvitrogen, Carlsbad, CA, USA44-244Gprimary antibody for phosphorylated Smad2 detection
p-Smad3 antibodyInvitrogen, Carlsbad, CA, USA44-246Gprimary antibody for phosphorylated Smad3 detection
PVDF membranesInvitrogen, Carlsbad, CA, USA88520protein transfer membrane for western blotting
RIPA lysis bufferBeyotime Biotechnology, Shanghai, ChinaP0013Bprotein extraction buffer for cell and tissue lysates
RNaseABeyotime Biotechnology, Shanghai, ChinaST579ribonuclease for RNA removal during DNA staining
SA-β-galactosidase staining kitBeyotime Biotechnology, Shanghai, ChinaC0602cellular senescence detection kit
SB431542MedChemExpress, Monmouth Junction, NJ, USAHY-10431TGF-β1 signaling pathway inhibitor
SDS-PAGE gelsInvitrogen, Carlsbad, CA, USAWG1403BX10polyacrylamide gels for protein electrophoresis
SKH1 hairless miceVitalriver, Beijing, Chinaanimal model for skin photo-aging studies
Smad2 antibodyInvitrogen, Carlsbad, CA, USA51-1300primary antibody for Smad2 detection
Smad3 antibodyInvitrogen, Carlsbad, CA, USA51-1500primary antibody for Smad3 detection
SOD Assay kitBeyotime Biotechnology, Shanghai, ChinaS0101Ssuperoxide dismutase activity detection kit
TGF-β1 antibodyAbcam, Cambridge, MA, USAab215715primary antibody for TGF-β1 detection
Triton X-100Sigma-Aldrich, St. Louis, MO, USAX-100non-ionic detergent for cell membrane permeabilization
TUNEL assay solutionBeyotime Biotechnology, Shanghai, ChinaC1086apoptosis detection reagent for DNA fragmentation
XyleneSigma-Aldrich, St. Louis, MO, USA247642organic solvent for tissue deparaffinization

References

  1. Gu, Y., Han, J., Jiang, C., Zhang, Y. Biomarkers, oxidative stress and autophagy in skin aging. Ageing Res Rev. 59, 101036 (2020).
  2. Chaudhary, M., Khan, A., Gupta, M. Skin ageing: pathophysiology and current market treatment approaches. Curr Aging Sci. 13 (1), 22-30 (2020).
  3. Lephart, E. D. Equol’s anti-aging effects protect against environmental assaults by increasing skin antioxidant defense and ECM proteins while decreasing oxidative stress and inflammation. Cosmetics. 5 (1), 16 (2018).
  4. Gromkowska-Kępka, K. J., Puścion-Jakubik, A., Markiewicz-Żukowska, R., Socha, K. The impact of ultraviolet radiation on skin photoaging—review of in vitro. studies. J Cosmet Dermatol. 20 (11), 3427-3431 (2021).
  5. Tsai, T. Y., et al. Djulis supplementation against oxidative stress and ultraviolet radiation-induced cell damage: the influence of antioxidant status and aging of skin in healthy subjects. J Cosmet Dermatol. 21 (7), 2945-2953 (2022).
  6. McCormick, E., et al. Topical nanoencapsulated cannabidiol cream as an innovative strategy combating UV-A-induced nuclear and mitochondrial DNA injury: a pilot randomized clinical study. J Am Acad Dermatol. 91 (5), 855-862 (2024).
  7. Ansary, T. M., Hossain, M. R., Kamiya, K., Komine, M., Ohtsuki, M. Inflammatory molecules associated with ultraviolet radiation-mediated skin aging. Int J Mol Sci. 22 (8), 3974 (2021).
  8. Deng, H., et al. Pterostilbene's protective effects against photodamage caused by UVA/UVB irradiation. Pharmazie. 73 (11), 651-658 (2018).
  9. Ho, C. Y., Dreesen, O. Faces of cellular senescence in skin aging. Mech Ageing Dev. 198, 111525 (2021).
  10. Bocheva, G., et al. Protective role of melatonin and its metabolites in skin aging. Int J Mol Sci. 23 (3), 1238 (2022).
  11. Rauf, A., et al. Honokiol: a review of its pharmacological potential and therapeutic insights. Phytomedicine. 90, 153647 (2021).
  12. Cardullo, N., Monti, F., Muccilli, V., Amorati, R., Baschieri, A. Reaction with ROO• and HOO• radicals of honokiol-related neolignan antioxidants. Molecules. 28 (2), (2023).
  13. Prasher, P., et al. Honokiol and its analogues as anticancer compounds: current mechanistic insights and structure-activity relationship. Chem Biol Interact. 386, 110747 (2023).
  14. Xin, L., et al. Honokiol alleviates radiation-induced premature ovarian failure via enhancing Nrf2. Am J Reprod Immunol. 90 (4), e13769 (2023).
  15. Faysal, M., et al. Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint. Chin Med. 18 (1), 154 (2023).
  16. Fan, X. X., et al. Honokiol improves depression-like behaviors in rats by HIF-1α-VEGF signaling pathway activation. Front Pharmacol. 13, 968124 (2022).
  17. Du, E., et al. Dietary honokiol supplementation improves antioxidant capacity, enhances intestinal health, and modulates cecal microbial composition and function of broiler chickens. Poult Sci. 103 (7), 103798 (2024).
  18. Sarrica, A., Kirika, N., Romeo, M., Salmona, M., Diomede, L. Safety and toxicology of magnolol and honokiol. Planta Med. 84 (16), 1151-1164 (2018).
  19. Zhuang, Q., et al. A validated ultra-HPLC-MS/MS method for determination of honokiol in human plasma and its application to a clinical pharmacokinetic study. Bioanalysis. 11 (11), 1085-1098 (2019).
  20. Guillermo, R. F., et al. Time- and dose-response effects of honokiol on UVB-induced skin cancer development. Drug Discov Ther. 6 (3), 140-146 (2012).
  21. Prasad, R., Singh, T., Katiyar, S. K. Honokiol inhibits ultraviolet radiation-induced immunosuppression through inhibition of ultraviolet-induced inflammation and DNA hypermethylation in mouse skin. Sci Rep. 7 (1), 1657 (2017).
  22. Dikalov, S., Losik, T., Arbiser, J. L. Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem Pharmacol. 76 (5), 589-596 (2008).
  23. Shen, C. Y., Jiang, J. G., Yang, L., Wang, D. W., Zhu, W. Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery. Br J Pharmacol. 174 (11), 1395-1425 (2017).
  24. Kim, K. K., Sheppard, D., Chapman, H. A. TGF-β1 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol. 10 (4), (2018).
  25. Lodyga, M., Hinz, B. TGF-β1—a truly transforming growth factor in fibrosis and immunity. Semin Cell Dev Biol. 101, 123-139 (2020).
  26. Liu, H., et al. TGF-β/Smads signaling pathway, Hippo-YAP/TAZ signaling pathway, and VEGF: their mechanisms and roles in vascular remodeling-related diseases. Immun Inflamm Dis. 11 (11), e1060 (2023).
  27. Huang, Y., et al. HIF-1α switches the functionality of TGF-β signaling via changing the partners of Smads to drive glucose metabolic reprogramming in non-small cell lung cancer. J Exp Clin Cancer Res. 40 (1), 398 (2021).
  28. Xie, X., et al. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis. Eur J Clin Invest. 52 (8), e13791 (2022).
  29. Guo, K., et al. Compound collagen peptide powder improves skin photoaging by reducing oxidative stress and activating TGF-β1/Smad pathway. Photochem Photobiol. 100 (6), 1874-1893 (2024).
  30. Yamane, T., et al. mTOR inhibition by rapamycin increases ceramide synthesis by promoting transforming growth factor-β1/Smad signaling in the skin. FEBS Open Bio. 6 (4), 317-325 (2016).
  31. Kataoka, S., et al. Honokiol acts as a potent anti-fibrotic agent in the liver through inhibition of TGF-β1/SMAD signaling and autophagy in hepatic stellate cells. Int J Mol Sci. 22 (24), 13678 (2021).
  32. Jang, H. Y., et al. Fisetin inhibits UVA-induced expression of MMP-1 and MMP-3 through the NOX/ROS/MAPK pathway in human dermal fibroblasts and human epidermal keratinocytes. Int J Mol Sci. 24 (24), 16212 (2023).
  33. Zheng, X., et al. Honokiol attenuates mitochondrial fission and cell apoptosis by activating Sirt3 in intracerebral hemorrhage. Chin Med J (Engl). 136 (6), 719-731 (2023).
  34. Xia, Y., Zhang, H., Wu, X., Xu, Y., Tan, Q. Resveratrol activates autophagy and protects from UVA-induced photoaging in human skin fibroblasts and the skin of male mice by regulating the AMPK pathway. Biogerontology. 25 (4), 649-664 (2024).
  35. Kim, J., Lee, N., Chun, Y. S., Lee, S. H., Ku, S. K. Krill oil's protective benefits against ultraviolet B-induced skin photoaging in hairless mice and in vitro. experiments. Mar Drugs. 21 (9), (2023).
  36. Zhang, C., et al. Combination of lyophilized adipose-derived stem cell concentrated conditioned medium and polysaccharide hydrogel in the inhibition of hypertrophic scarring. Stem Cell Res Ther. 12 (1), 23 (2021).
  37. Sun, G., et al. Panax ginseng Meyer cv. Silvatica phenolic acids protect DNA from oxidative damage by activating Nrf2 to protect HFF-1 cells from UVA-induced photoaging. J Ethnopharmacol. 302 (Pt A), 115883 (2023).
  38. Fadadu, R. P., Wei, M. L. Ultraviolet A radiation exposure and melanoma: a review. Melanoma Res. 32 (6), 405-410 (2022).
  39. Wlaschek, M., Maity, P., Makrantonaki, E., Scharffetter-Kochanek, K. Connective tissue and fibroblast senescence in skin aging. J Invest Dermatol. 141 (4 Suppl), 985-992 (2021).
  40. Duan, Y., et al. Handelin reduces ultraviolet A-induced photoaging by inhibiting reactive oxygen species generation and enhancing autophagy. Tohoku J Exp Med. 259 (3), 189-198 (2023).
  41. Liu, S., et al. Oral supplementation of sea cucumber and its hydrolysate mitigates ultraviolet A-induced photoaging in hairless mice. J Sci Food Agric. 102 (5), 1987-1994 (2022).
  42. Liu, S., et al. Gly-Pro protects normal human dermal fibroblasts from UVA-induced damages via MAPK-NF-κB signaling pathway. J Photochem Photobiol B. 237, 112601 (2022).
  43. Lu, Z., et al. Hesperetin attenuates UVA-induced photodamage in human dermal fibroblast cells. J Cosmet Dermatol. 21 (11), 6261-6269 (2022).
  44. Michel, P., et al. Anti-inflammatory, antioxidant and photoprotective activity of standardised Gaultheria procumbens L. leaf, stem, and fruit extracts in UVA-irradiated human dermal fibroblasts. J Ethnopharmacol. 319 (Pt 2), 117219 (2024).
  45. Fu, H., et al. Tremella fuciformis polysaccharides inhibit UVA-induced photodamage of human dermal fibroblast cells by activating and up-regulating Nrf2/Keap1 pathways. J Cosmet Dermatol. 20 (12), 4052-4059 (2021).
  46. Park, C., et al. Honokiol ameliorates oxidative stress-induced DNA damage and apoptosis of C2C12 myoblasts by regulating ROS generation and the mitochondrial pathway. Anim Cells Syst. 24 (1), 60-68 (2020).
  47. Chen, Q., et al. Metformin attenuates UVA-induced skin photoaging by suppressing mitophagy and the PI3K/AKT/mTOR pathway. Int J Mol Sci. 23 (13), 6969 (2022).
  48. Wang, M., Guo, Y., Wan, M., Chen, Z., Zhong, J. L. TAZ reduces UVA-mediated photoaging through regulation of cell proliferation in skin fibroblasts. Photochem Photobiol. 99 (1), 153-159 (2023).
  49. Han, S., et al. Inhibitory effect of seawater pearl hydrolysate on UVA-induced photoaging of human skin fibroblasts. Evid Based Complement Alternat Med. 2022, 1558288 (2022).
  50. Alam, A., et al. Computational development of new inhibitors for apoptosis stimulating protein of p53 (iASPP) using pharmacophore modeling, docking, and MD simulation approaches. J Cancer Biomol Ther. 1 (2), 1-9 (2024).
  51. Bai, G. L., et al. Rapamycin protects skin fibroblasts from UVA-induced photoaging by inhibition of p53 and phosphorylated HSP27. Front Cell Dev Biol. 9, 633331 (2021).
  52. Zhang, J., Yu, H., Man, M. Q., Hu, L. Aging in the dermis: fibroblast senescence and its significance. Aging Cell. 23 (2), e14054 (2024).
  53. Liu, H., Dong, J., Du, R., Gao, Y., Zhao, P. Collagen study advances for photoaging skin. Photodermatol Photoimmunol Photomed. 40 (1), e12931 (2024).
  54. Fisher, G. J., et al. Skin aging from the perspective of dermal fibroblasts: the interplay between adaptation to the extracellular matrix microenvironment and cell autonomous processes. J Cell Commun Signal. 17 (3), 523-529 (2023).
  55. Li, F., et al. Discovery of matrix metalloproteinase inhibitors as anti-skin photoaging agents. Eur J Med Chem. 267, 116152 (2024).
  56. Song, M. J., et al. Downregulation of carnitine acetyltransferase by promoter hypermethylation regulates ultraviolet-induced matrix metalloproteinase-1 expression in human dermal fibroblasts. J Dermatol Sci. 116 (2), 70-77 (2024).
  57. Choi, S. I., et al. Eisenia bicyclis extract repairs UVB-induced skin photoaging in vitro and in vivo.: photoprotective effects. Mar Drugs. 19 (12), (2021).
  58. Kim, M. K., et al. Dual role of enhancer of zeste homolog 2 in the regulation of ultraviolet radiation-induced matrix metalloproteinase-1 and type I procollagen expression in human dermal fibroblasts. Matrix Biol. 119, 112-124 (2023).
  59. Xue, N., Liu, Y., Jin, J., Ji, M., Chen, X. Chlorogenic acid prevents UVA-induced skin photoaging through regulating collagen metabolism and apoptosis in human dermal fibroblasts. Int J Mol Sci. 23 (13), (2022).
  60. Meng, L., et al. NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways. Sci Adv. 9 (31), eadd4222 (2023).
  61. Li, W., et al. Echinacoside exerts anti-tumor activity via the miR-503-3p/TGF-β1/Smad axis in liver cancer. Cancer Cell Int. 21 (1), 304 (2021).
  62. Xiang, D., et al. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Phytomedicine. 78, 153294 (2020).
  63. Jiang, H., Zhou, X., Chen, L. Asiaticoside delays senescence and attenuates ROS generation in UV-exposed cells through regulation of the TGF-β1/Smad pathway. Exp Ther Med. 24 (5), 667 (2022).
  64. Tong, T., Park, J., Moon, Y., Kang, W., Park, T. α-Ionone protects against UVB-induced photoaging in human dermal fibroblasts. Molecules. 24 (9), 1688 (2019).
  65. Liu, X. Y., Hwang, E., Park, B., Xiao, Y. K., Yi, T. H. Photoprotective and anti-inflammatory properties of vina-ginsenoside R7 ameliorate ultraviolet B-induced photodamage in normal human dermal fibroblasts. Appl Biochem Biotechnol. 189 (3), 729-744 (2019).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

TGF Beta SignalingSmad PathwayHDF CellsOxidative StressCell Viability AssayWestern BlotFlow Cytometry
Contact Us
Recommend to Library

Privacy

Terms of Use

Policies

Copyright © 2026 MyJoVE Corporation. All rights reserved.